Sexually-Transmitted Diseases Department
(STDD) Antenatal Clinic (ANC) General Hospital Population (GHP) 3,533 A modification of the Whitechapel technique (ACP Broadsheet 41, 1969) was used for the RPCF test (1 1 MHD of complement and a fixation period of 30 min. at room temperature followed by 30 min. at 370C.). Standard techniques were used for the VDRL slide test (Harris, Rosenberg, and Reidel, 1946) and the FTA-ABS test (Hunter, Deacon, and Meyer, 1964) . TPHA TEST This was carried out by a modification of the micromethod described by the suppliers of the reagents (Fujizoki Pharmaceutical Company, Tokyo, Japan). Each kit comprised lyophilized test cells (antigen coated) and control cells, absorbing diluent to remove non-specific reactions, and a positive control serum. Test and control cells were re-constituted and diluted 1 in 6-5 as recommended by the manufacturer. Positive and negative control sera were included in each batch of screening tests and the positive serum titrated whenever any quantitative tests were performed.
(a) Screening tests Sera were inactivated by heating at 56°C. for 30 From Table I All specimens which were positive in all of the three screening tests were also FTA-ABS positive. Cases of untreated syphilis in this group were mainly of late syphilis (late syphilis, twelve sera; early syphilis, three sera). Sera found to be positive in both the VDRL and TPHA test and negative in the RPCF test also showed 100 per cent. agreement with the FTA-ABS test and there were no cases of untreated syphilis in this group.
The TPHA test failed to detect ten sera from patients with syphilis which were positive in the FTA-ABS. Eight of the sera were from cases of untreated primary syphilis (two were VDRL and RPCF positive and six were positive in the VDRL only) and two were specimens from a case of treated latent syphilis (positive in the VDRL only). The (Table IV) ; sera from five of these patients gave a reciprocal TPHA titre of 160 or more on at least one occasion but repeat specimens were negative. The remaining ten patients (STDD 4; ANC 3; GHP 3), all in the 'very weak positive' category, attended once only and could not therefore be fully evaluated.
Non-specific agglutination Four sera agglutinated both test and control cells. These sera were negative in the VDRL, RPCF, and FTA-ABS tests. This represented 0 05 per cent. of all sera tested.
The pattern of agglutination of the antigen-coated cells by these non-specific sera was found to differ from the normal agglutination pattern (Figure) . The reason this for distinctive settling pattern is obscure but these sera could invariably be distinguished from genuine reactors in the routine screen in the absence of control cells. Johnston (1972) and Sequeira and Eldridge (1973) . In contrast to these findings Luger and Spendlingwimmer (1973) (Table II) . However, five of these sera were also reactive in the FTA-ABS test. Garner, Backhouse, Daskalopoulos, and Walsh (1973) , in contrast to our findings and their previous work (Garner and others, 1972) , found 11-3 per cent.
of 274 biological false positive sera showed false positive TPHA reactions. From a survey of only 306 sera, Blum, Ellner, McCarthy, and Papachristos (1973) calculated that the TPHA test gave a false positive rate of 8 8 per cent. The reagents used in the latter study, unlike the previous one, were not supplied by the Fujizoki Company.
Sequeira and Eldridge (1973), however, using an alternative TPHA technique in which sensitized fowl erythrocytes are used in place of sheep erythrocytes, reported a specificity similar to ours (99-8 per cent.). Buist, Pertile, and Morris (1973) (Kiraly, Jobbagy, and Kovats, 1967) . Another reason for false positive TPHA results could be a failure of the control cells to show agglutination in the presence of heterophil antibody. Cox, Logan, and Stout (1971) reported that threeof one-hundred serafrom patients withinfectious mononucleosis gave false positive TPHA reactions and did not agglutinate the control, unsensitized, erythrocytes. There was one such specimen in our survey. The rate of non-specific agglutination in our tests, less than 1 per thousand specimens, was relatively low compared to a rate of approximately 5 per thousand reported by Garner and others, (1972 
